4YoshimuraY·Regulatory system and physiological significance of local factors in the ovary during follicular devepment and maturation[J]. Nippon Sanka FejinkaGakkai Zossh,i 1995, 47 (5): 763.
5Loret-de-Mola JR,Goldfab JM,Hecht BR,et al Gonadotropins induce higher active renin levels in the follicular fluid of normal and hyperstimulated cycles[J].Gynecol Endocrinol,1999,13:155-160.
6Hacihanefioglu B,Somunkiran A,Mahmutoglu I,et al. Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome [J]. Fertil Steril,2002,77(3):526-528.
7Morris RS, Wong IL, Hatch IE et al.Prorenin is elevated in polycystic ovary syndrome and may reflect hyperandrogenism [J].Fertil Steril. 1995,64 (6): 1099.
9Matuszkiewicz-Rowinska J,Skorzewska K,Radowicki S,et al.Menstrum disturoances and alternations in hypophyseal gonadal axis in end-stage premenopausal women undergoing hemodialysis: a multi-center study[J]. PolArch Med Wewy. 2003, 109: 609-615.
10Dal Maso RC, Cavagna Neto M, Yu L, et al.Sex homrones profile in women on dialysis program in treatment with erythropoietin[J]. Rev Assoc Med Bras, 2003,49: 418-423.
7Jaatinen TA, Matinlarui I, Anttila L, et al. Serum total rennin is elevated in women with polycystic ovary syndrome [J]. Fertil Steril, 1995, 63(5):1000-1004.
8Battaglia C, Artini PG, Ambrogio G, et al. The role of color Doppler imaging in the diagnosis of polycystic ovary syndrome [J]. Am J Obstet Gynecol, 1995, 172(1 Pt 1): 108-113.
9Topalski-Fistes TN, Bujas M, Maticki-Sekulic M, et al. Hyperprolactinemia and disorders of the menstrual cycle [J]. Med Pregl, 1999, 52(1-2):39-43.
10Hacihanefioglu B, Somunkiran A, Mahmutoglu I, et al. Effect of hypertension therapy with the angiotensin-converting enzyme inhibitor lisinopril on hyperandrogenism in women with polycystic ovary syndrome [J]. Fertil Steril, 2002, 77(3):526-528.
